Elizabeth E Evans

USPTO Granted Patents = 17 (Patent Applications = 6)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 128(Granted Patents)

Location History:

Rochester, NY (US) (2007 - 2009)
Bloomfield, NY (US) (2010 - 2024)

Company Filing History:

University of Rochester

patents

2 out of 290

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

4. 1 out of 1

The Sydney Children's Hospital Network

patent

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12201719 - Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy (2025-01-21),

2. 12070500 - Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis (2024-08-27),

3. 11660330 - Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy (2023-05-30),

4. 11597765 - Use of semaphorin-4D binding molecules for the treatment of Rett syndrome (2023-03-07),

5. 11572408 - Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent (2023-02-07),

6. 11078295 - Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases (2021-08-03),

7. 10526414 - Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases (2020-01-07),

8. 9828435 - Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency (2017-11-28),

9. 9243068 - Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases (2016-01-26),

10. 8790652 - Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis (2014-07-29),

11. 8637026 - Anti-C35 antibody combination therapies and methods (2014-01-28),

12. 7968688 - Antibodies that bind to the C35 polypeptide (2011-06-28),

13. 7910551 - Gene differentially expressed in breast and bladder cancer and encoded polypeptides (2011-03-22),

14. 7879990 - Polynucleotides encoding antibodies that bind to the C35 polypeptide (2011-02-01),

15. 7750125 - Antibodies that bind to the C35 polypeptide (2010-07-06),

Title: The Innovative Journey of Elizabeth E Evans

Introduction: Elizabeth E Evans, a pioneering inventor hailing from Rochester, NY, has made significant contributions to the world of technology and innovation through her groundbreaking inventions.

Latest Patents: Elizabeth E Evans holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With a career spanning over two decades, Elizabeth E Evans has worked for leading tech companies, where she spearheaded research and development projects that have resulted in cutting-edge inventions.

Collaborations: Elizabeth E Evans has collaborated with top researchers and engineers from renowned universities and research institutions, fostering a culture of innovation and excellence in all her projects.

Conclusion: Elizabeth E Evans continues to inspire the next generation of inventors with her passion for innovation and her relentless pursuit of technological advancement.

This text is generated by artificial intelligence and may not be accurate.